Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs

New biologic therapeutics for ulcerative colitis and Crohn's disease

(2014) Shilan Mozaffari et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease

(2013) T. G. J. de Meij et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease

(2013) M J Casanova et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Editorial Current opinion on treatment of inflammatory bowel disease in pregnant women

(2013) Pooneh Salari et al.   Archives of Medical Science

Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study

(2013) Martin Bortlik et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient

(2012) F. M. Habal et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Adverse Cardiovascular Effects of Antirheumatic Drugs: Implications for Clinical Practice and Research

(2012) Armen Yuri Gasparyan et al.   CURRENT PHARMACEUTICAL DESIGN

Systematic Review and Meta-analysis on the Effects of Thiopurines on Birth Outcomes from Female and Male Patients with Inflammatory Bowel Disease

(2012) Mona Akbari et al.   INFLAMMATORY BOWEL DISEASES

Maternal inflammatory bowel disease has short and long-term effects on the health of their offspring: A multicenter study in Israel

(2012) Iris Dotan et al.   Journal of Crohns & Colitis

The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy

(2012) J. R. Hutson et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Vasculitis Associated With Tumor Necrosis Factor-α Inhibitors

(2012) Olayemi Sokumbi et al.   MAYO CLINIC PROCEEDINGS

Is safety infliximab during pregnancy in patients with inflammatory bowel disease?

(2012) Federico Argüelles-Arias et al.   REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Pregnancy related issues in inflammatory bowel disease: Evidence base and patients' perspective

(2012) Christian P Selinger   WORLD JOURNAL OF GASTROENTEROLOGY

High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy

(2011) Z. Zelinkova et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy

(2011) Fabian Schnitzler et al.   INFLAMMATORY BOWEL DISEASES

The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD)

(2011) Lisa Shim et al.   Journal of Crohns & Colitis

Anti-TNF Antibody Therapy for Inflammatory Bowel Disease During Pregnancy: A Clinical Review

(2010) Marwa Mourabet et al.   CURRENT DRUG TARGETS

Efficacy and Tolerability of Immunoregulators and Antibiotics in Fistulizing Crohns Disease: A Systematic Review and Meta-analysis of Placebo-controlled Trials

(2010) Shekoufeh Nikfar et al.   CURRENT PHARMACEUTICAL DESIGN

Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study

(2010) J. Coelho et al.   GUT

On the benefit of Teucrium in murine colitis through improvement of toxic inflammatory mediators

(2010) Amir Hossein Abdolghaffari et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

A Review and Meta-analysis of the Efficacy of Antibiotics and Probiotics in Management of Pouchitis

(2010) S. Nikfar et al.   International Journal of Pharmacology

Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: A case–control study

(2010) Tamás Molnár et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Early pregnancy azathioprine use and pregnancy outcomes

(2009) Brian J. Cleary et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

(2009) Gert Van Assche et al.   Journal of Crohns & Colitis

A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration Database

(2009) J. D. CARTER et al.   JOURNAL OF RHEUMATOLOGY

Effects of Adalimumab Maintenance Therapy on Health-Related Quality of Life of Patients With Crohn's Disease: Patient-Reported Outcomes of the CHARM Trial

(2008) Edward V. Loftus et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Comparison of Mesalazine and Balsalazide in Induction and Maintenance of Remission in Patients with Ulcerative Colitis: A Meta-Analysis

(2008) Roja Rahimi et al.   DIGESTIVE DISEASES AND SCIENCES

A Meta-Analysis of the Efficacy of Sulfasalazine in Comparison with 5-Aminosalicylates in the Induction of Improvement and Maintenance of Remission in Patients with Ulcerative Colitis

(2008) Shekoufeh Nikfar et al.   DIGESTIVE DISEASES AND SCIENCES

On the Use of Herbal Medicines in Management of Inflammatory Bowel Diseases: A Systematic Review of Animal and Human Studies

(2008) Roja Rahimi et al.   DIGESTIVE DISEASES AND SCIENCES

Inhibition of Tumor Necrosis Factor and Nitrosative/Oxidative Stresses byZiziphora Clinopoides(Kahlioti); A Molecular Mechanism of Protection Against Dextran Sodium Sulfate-Induced Colitis in Mice

(2008) Noushin Amini-Shirazi et al.   TOXICOLOGY MECHANISMS AND METHODS

Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: A meta-analysis

(2007) Roja Rahimi et al.   REPRODUCTIVE TOXICOLOGY